Novo Nordisk A/S
NVON
Weiss Ratings | NVON - | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Unrated | |||
Risk Index | Unrated | |||
Risk Grade | U | |||
Reward Grade | U | |||
Rating Factors | NVON - | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Unrated | |||
Growth Index | Unrated | |||
Efficiency Index | Unrated | |||
Solvency Index | Unrated | |||
Total Return Index | Unrated | |||
Volatility Index | Unrated | |||
Beta / Standard Deviation | NVON - | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -- | |||
Price History | NVON - | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 24.26% | |||
30-Day Total Return | -- | |||
60-Day Total Return | -- | |||
90-Day Total Return | -- | |||
Year to Date Total Return | 8.65% | |||
1-Year Total Return | -- | |||
2-Year Total Return | -- | |||
3-Year Total Return | -- | |||
5-Year Total Return | -- | |||
52-Week High % Change | -28.61% | |||
52-Week Low % Change | 1.45% | |||
Price | NVON - | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $10.80 | |||
52-Week Low Price | $7.60 | |||
52-Week Low Price (Date) | Mar 31, 2025 | |||
52-Week High Price (Date) | Feb 25, 2025 | |||
Valuation | NVON - | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 308.08B | |||
Enterprise Value | 319.16B | |||
Price/Earnings (TTM) | 2.35 | |||
Earnings Per Share (TTM) | 3.28 | |||
Earnings Per Share Growth | 21.47% | |||
Price/Earnings To Growth | 0.11 | |||
Price/Sales (TTM) | 0.82 | |||
Price/Book (Q) | 1.72 | |||
Enterprise Value/Revenue (TTM) | 7.58 | |||
Price | $10.55 | |||
Enterprise Value/EBITDA (TTM) | 14.70 | |||
Enterprise Value/EBIT | 15.75 | |||
Market Cap Category | Mega Cap | |||
Dividends and Shares | NVON - | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 4.46B | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | 44.06% | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | NVON - | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 45 44 44 88 88 | |||
Address | -- | |||
Website | www.novonordisk.com | |||
Country | Denmark | |||
Year Founded | 1923 | |||
Profitability | NVON - | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 48.16% | |||
Profit Margin | 34.80% | |||
Management Effectiveness | NVON - | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 22.77% | |||
Return on Equity | 82.02% | |||
Income Statement | NVON - | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 42.09B | |||
Total Revenue (TTM) | 42.09B | |||
Revenue Per Share | $9.45 | |||
Gross Profit (TTM) | 35.77B | |||
EBITDA (TTM) | 21.71B | |||
EBIT (TTM) | 20.27B | |||
Net Income (TTM) | 14.65B | |||
Net Income Avl. to Common (TTM) | 14.65B | |||
Total Revenue Growth (Q YOY) | 28.79% | |||
Earnings Growth (Q YOY) | 27.24% | |||
EPS Diluted (TTM) | 3.28 | |||
EPS Diluted Growth (Q YOY) | 27.85% | |||
Balance Sheet | NVON - | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 3.65B | |||
Cash Per Share (Q) | $0.82 | |||
Total Current Assets (Q) | 22.34B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 19.92B | |||
Current Ratio (Q) | 0.740 | |||
Book Value Per Share (Q) | $4.49 | |||
Total Assets (Q) | 64.66B | |||
Total Current Liabilities (Q) | 30.20B | |||
Total Debt (Q) | 14.27B | |||
Total Liabilities (Q) | 44.74B | |||
Total Common Equity (Q) | 19.92B | |||
Cash Flow | NVON - | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -18.53B | |||
Cash from Financing (TTM) | 1.12B | |||
Net Change in Cash (TTM) | 241.41M | |||
Levered Free Cash Flow (TTM) | 9.07B | |||
Cash from Operations (TTM) | 17.59B | |||